<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have previously shown that 12-O-tetradecanoylphorbol-13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) which activates expression of the latent genome of the Epstein-Barr virus (EBV) in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cells induces the synthesis of two cellular anti-EBNA-1 competitor proteins, anti-EBNA-1.1 and anti-EBNA-1.2 </plain></SENT>
<SENT sid="1" pm="."><plain>Both anti-EBNA-1 proteins can uncouple the specific binding of the EBNA-1 to the region required for EBV plasmid maintenance (oriP) </plain></SENT>
<SENT sid="2" pm="."><plain>Here, we show by DNase I footprinting that the binding sites on oriP for the EBNA-1 and the anti-EBNA-1 proteins were indistinguishable </plain></SENT>
<SENT sid="3" pm="."><plain>The proteins bound to the 30-bp tandem repeats of the oriP </plain></SENT>
<SENT sid="4" pm="."><plain><z:chebi fb="3" ids="17754">Glycerol</z:chebi>-gradient centrifugation and gel retardation assay revealed that a 60-kDa protein formed the anti-EBNA-1.1-DNA complex and a 40-kDa protein formed the anti-EBNA-1.2-DNA complex </plain></SENT>
</text></document>